'Pharmacological therapy' presentation slideshows

2012 SEMDSA Guideline for the Management of Type 2 Diabetes Mellitus

2012 SEMDSA Guideline for the Management of Type 2 Diabetes Mellitus. Aslam Amod 1st FCPSA Congress 19 May 2012, Cape Town. The Guideline & Steering Committee. The Guideline & Steering Committee (2). The Guideline & Steering Committee (3). The Guideline & Steering Committee (4).

1.33k views • 73 slides

836 views • 70 slides

MANGEMENT OF COPD

MANGEMENT OF COPD. Document Goals and Objectives (1). The Standards for the Diagnosis and Treatment of Patients with COPD document updates the position papers on COPD published by the ATS and the ERS in 1995.

853 views • 61 slides

MUSCULOSKELETAL SYSTEM

MUSCULOSKELETAL SYSTEM. Risk Factors For M/S Problems. Overweight Family hx of arthritis Systemic problems Occupational risks Plays contact sports Exercises less than twice per week Has poor eyesight Any problem that would impede ADLs. Key S&S That Suggest M/S Problems.

900 views • 56 slides

COPD ASTHMA and RF

COPD ASTHMA and RF. Definition of COPD. Chronic Obstructive Pulmonary Disease (COPD) is a common preventable and treatable disease state characterised by persistent respiratory symptom and airflow limitation that is not fully reversible.

692 views • 38 slides

Medically Unexplained Symptoms (somatisation)

Medically Unexplained Symptoms (somatisation). Dr Anna Fryer ST6 Liaison Psychiatry, Manchester Royal Infirmary. Learning objectives. Understand what somatisation is and when it is diagnosed Knowledge of the epidemiology, diagnosis, treatment and management of these disorders

988 views • 35 slides

Efficacy Of ICDs For The Prevention Of Sudden Death In Patients With Hypertrophic Cardiomyopathy

Efficacy Of ICDs For The Prevention Of Sudden Death In Patients With Hypertrophic Cardiomyopathy. *Maron BJ et al. N Engl J Med. 2000:342;365-373. Etiology: Autosomal dominant trait caused by a variety of genetic mutations of sarcomere proteins

480 views • 34 slides

??? ???? ?????? ??????

??? ???? ?????? ??????. COPD Guide lines. What's New ?. Prof. Ashraf M. Hatem. Professor of Chest Diseases. Dr. Raef Hosny Emam. Lecturer of chest diseases. Faculty of Medicine - Cairo University. ERS-ATS COPD Guidelines. Document Goals and Objectives.

490 views • 28 slides

POSTPATUM PSYCHIATRIC SYNDROMES

396 views • 26 slides

Chapter 10

Clinical Neuroscience by Kelly Lambert and Craig Howard Kinsley. Chapter 10. Schizophrenia. Overview of Schizophrenia. History, Descriptions, and Definitions Contemporary Views of Schizophrenia Views of a Schizophrenic Mind. Neurobiology of Schizophrenia. Genetic Factors.

93 views • 9 slides

Peptic ulcer

Peptic ulcer. Definition it is a excavation (hallow-out area) that forms in the mucosal wall of the stomach, duodenum or esophagus. People at risk. Age Gender H pylori Excessive HCL Stess Ingestion of milk, caffienated beverages Smoking Alcohol Spicy food Familial Group O people

747 views • 7 slides

Global Insomnia Market is expected to reach USD 3.01 billion by 2025, from USD 3.36 billion in 2017 growing at a CAGR of 5.80% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

62 views • 6 slides

Insomnia Market is expected to grow at a CAGR 4.5% during the forecast period of 2017-2023

The global insomnia market is all set to gain substantially from a moderate CAGR of 4.5% during the forecast period (2017-2023), claims Market Research Future (MRFR) in an extensively researched study. Insomnia, across the world, is on the rise aggravated much by anxiety and stress which are by-products of the changing lifestyle. In a roundabout a way this also triggers the global insomnia market.

69 views • 6 slides